Federated Hermes, Inc. Royalty Pharma PLC Transaction History
Federated Hermes, Inc.
- $43 Billion
- Q4 2024
A detailed history of Federated Hermes, Inc. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Federated Hermes, Inc. holds 7,000 shares of RPRX stock, worth $228,130. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,000
Previous 7,000
-0.0%
Holding current value
$228,130
Previous $198,000
10.1%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding RPRX
# of Institutions
428Shares Held
294MCall Options Held
508KPut Options Held
118K-
Morgan Stanley New York, NY39.5MShares$1.29 Billion0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.4MShares$1.22 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$750 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA17MShares$553 Million0.79% of portfolio
-
Baillie Gifford & CO14.1MShares$461 Million0.28% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.2B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...